Who is the CEO of Isracann Biosciences Inc.?

The CEO of Isracann Biosciences Inc. is Ajay Singh Kaila.

What industry does Isracann Biosciences Inc. belong to?

Isracann Biosciences Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Where is Isracann Biosciences Inc. headquartered?

Isracann Biosciences Inc. is headquartered at 595 Burrard Street, Vancouver, BC, V7X 1L3, CA.

What is the IPO date of Isracann Biosciences Inc.?

Isracann Biosciences Inc. went public on October 4, 2010.

How many employees does Isracann Biosciences Inc. have?

The total number of employees at Isracann Biosciences Inc. is disclosed periodically in the company's annual financial reports.

Isracann Biosciences Inc.

IPOT.CN•CNQ

Healthcare

Drug Manufacturers - Specialty & Generic

CA$0.01

CA$0.00(0.00%)

Isracann Biosciences Inc. (IPOT.CN) Company Profile & Overview

Explore Isracann Biosciences Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Isracann Biosciences Inc. (IPOT.CN) Company Profile & Overview

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEOAjay Singh Kaila

Contact Information

https://www.isracann.com

595 Burrard Street, Vancouver, BC, V7X 1L3

Company Facts

IPO DateOct 4, 2010

CountryCA

Frequently Asked Questions

;